A report using global data mining and multiple reaction monitoring method suggested that ANLN may serve as a potential biomarker when combined with filamin-B (FLNB) to improve the discrimination of HCC patients from the healthy controls [24]. Here, FLNB is linked to hepatocellular carcinoma.